Reunion Neuroscience (REUN) Announces $13.1 Million Take-Private Transaction with MPM BioImpact
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Reunion Neuroscience Announces US$13.1 Million Take-Private Transaction with MPM BioImpact
June 1, 2023 7:30 AM EDTReunion Common Shareholders to Receive Consideration of US$1.12 Per Share in Cash
Represents a 43.1% Premium to the 30-Day Volume Weighted Average Price
Reunion Presents Encouraging Phase 1 Final Analysis at American Society of Clinical Psychopharmacology Annual Meeting, Enabling Advancement into Phase 2 in 2H 2023
TORONTO, June 01, 2023 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) (Reunion or... More
